We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ascentage Pharma Group International Unsponsored ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

BioNTech (NasdaqGS:BNTX) reported a 2.49% weekly price decline following its announcement of diminished Q4 2024 earnings, where sales and net income significantly dropped compared to the previous ...

CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in ...

With that comes an average price target of $144.05, a high of $170, and a low of $120. This represents a potential 35.27% upside for BNTX stock. These ratings and price targets will likely change ...

BioNTech is expanding its oncology pipeline with FixVac, iNeST, and BNT327 for individualized cancer treatments. Read why I ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.